Analysis Offers Insight into Patients Most Likely to Derive Benefit from Tofacitinib
HomeHome > Blog > Analysis Offers Insight into Patients Most Likely to Derive Benefit from Tofacitinib

Analysis Offers Insight into Patients Most Likely to Derive Benefit from Tofacitinib

May 21, 2023

Tofacitinib 5 mg: 0.89 (95% CI, 0.46-1.70)

Tofacitinib 10 mg: 1.48 (95% CI, 0.82-2.65)

Tofacitinib 5 mg: 1.40 (95% CI, 1.08-1.82)

Tofacitinib 10 mg: 1.48 (95% CI, 1.14-1.92)

With ASCVD Tofacitinib 5 mg: Tofacitinib 10 mg Without ASCVD Tofacitinib 5 mg Tofacitinib 10 mg